Peptide Identity vs. Purity: What's the Difference?

Peptide identity and peptide purity are two of the most commonly confused terms in analytical chemistry. They ask different questions, require different evidence, and one cannot be used as a substitute for the other.

• Identity asks whether the material is the compound it claims to be.
• Purity asks how much of the detected material is attributed to the principal component under the stated analytical method.

A single result can answer one of those questions well and the other not at all. Understanding the distinction is essential when reading a Certificate of Analysis or comparing batch documentation.

What does peptide identity mean?

Identity asks whether the analysed material corresponds to the compound stated on the label. In the current GLUUM. testing program, identity is tested by chromatographic comparison against a reference standard under the applicable method conditions.

That identity result is reported separately from purity and quantitative content. A purity percentage cannot be substituted for the identity comparison.

What does peptide purity mean?

Purity is a compositional measurement. It describes what proportion of the detected material corresponds to the principal component under a specific chromatographic method. In a typical HPLC report, purity is derived from the relative area of the principal peak compared with the total integrated peak area.

Purity results are inherently method-dependent:

• The column chemistry, solvent system, and gradient determine what separates and what co-elutes.
• Peak area is not identical to mass fraction; different molecules can have different detector responses.
• Impurities that are not separated from the principal peak, or that the detector does not see, will not appear in the purity calculation.

This means a purity value is a precise statement about a specific analytical run, not a universal quality score.

Why a 99% purity result does not prove identity

Imagine a chromatogram that shows one large peak at 99% of the total area. That result tells you one component dominates the detectable material under the method used. It does not tell you whether that dominant component is the peptide named on the label.

A different compound — for example a closely related sequence variant, truncated analogue, or synthetic precursor — could in principle produce a similarly dominant peak. If identity was not separately compared against the reference standard, the 99% figure would describe relative composition without establishing identity.

This is why identity and purity are reported separately on a well-constructed COA. Each answers a different question, and neither implies the other.

How the three reported attributes differ

The current testing program reports three separate attributes.

HPLC purity separates the components in a mixture. It is used for:

• showing how many detectable species are present
• estimating the relative amount of the principal component
• revealing impurity patterns that the method resolves and detects; unresolved co-eluting species may remain hidden

Chromatographic identity compares the sample against a reference standard under the stated conditions. Quantitative analysis reports the actual measured amount of material in the vial. No one result substitutes for the other two.

Identity, purity, content, sterility, and stability are different attributes

These analytical questions are often grouped together, but they measure different things and typically require different method families. The exact methods used vary by application, lab protocol, and regulatory context.

A result in one column does not imply a result in another. A pure sample may still be misidentified; an identified sample may still have low purity; a high-purity, correctly identified sample may still fail a sterility or endotoxin specification if those tests were not performed or not reported.

What to look for on a COA

A useful peptide COA separates identity evidence from purity evidence and links both to a specific batch. For a detailed walkthrough, see How to Read a Peptide Certificate of Analysis.

Check specifically for:

• an identity result from chromatographic comparison against a reference standard
• a purity result with the chromatographic method named
• a batch or lot identifier that matches your material
• a test date and analytical source
• clear statements about what was not tested, if any quality attributes are absent

You can also check the live COA Library to see what documentation GLUUM currently publishes for available compounds.

Common interpretation mistakes

• Treating purity as identity. A 99% purity figure does not prove the principal peak is the labelled compound.
• Treating one result as proving everything. Identity, HPLC purity, and quantitative content answer different questions.
• Ignoring the batch link. Results from a previous batch do not automatically apply to the material in front of you.
• Assuming more decimals means better data. Precision must be justified by the method and the instrument; extra digits can be misleading.
• Comparing results from different methods as if identical. Two purity values from different columns, gradients, or detectors may not be comparable.
• Confusing purity with content. Purity is a relative area measurement; content asks how much peptide is actually present by mass.

Frequently asked questions

Can a sample be pure but misidentified? Yes. A chromatogram can show one dominant peak with high relative area while the identity of that peak remains unconfirmed. Without orthogonal identity evidence, high purity does not prove the material is the intended compound.

Can identity be correct but purity low? Yes. A sample can be the right peptide yet contain significant impurities, related substances, or degradation products. Identity confirms the species; purity describes how clean the sample is.

Is HPLC a purity or identity test? HPLC is primarily a separation and purity technique. Retention-time matching against a reference standard can support identity, but retention time alone is generally not considered sufficient proof of identity because different compounds can co-elute.

Does HPLC purity report quantitative vial content? No. HPLC purity reports relative chromatographic composition. Quantitative analysis separately reports the actual measured material in the vial.

What does 99% purity actually tell you? It tells you that, under the stated chromatographic method, roughly 99% of the integrated detector response was attributed to the principal peak. It does not establish identity, content, sterility, endotoxin status, or stability.

Why should COAs show the method? A result without a method has no defined scope. The method explains what was measured, how it was measured, and what limits apply. This is what makes a COA reproducible and interpretable.

References and further reading

• FDA Analytical Procedures and Methods Validation for Drugs and Biologics
• FDA/ICH Q2(R2) Validation of Analytical Procedures
• FDA/ICH Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances
• Reference Standards to Support Quality of Synthetic Peptide Therapeutics (PMID 36949371)

Research use notice. This article is educational material about analytical testing only. It is not medical advice, does not describe biological effects, and contains no human-use instructions. All GLUUM compounds are for laboratory research use only. Not for human consumption.

What a purity method must demonstrate

A large peak does not demonstrate separation from plausible interfering substances. Ask what a procedure needed to distinguish and what evidence shows that it could.

ICH Q2(R2) discusses specificity/selectivity in terms of identification or quantitation being affected by likely impurities, degradation products, related substances and matrix components. It is a pharmaceutical-method reference, not validation of an individual research certificate. ICH Q2(R2), §3.1

Identification must discriminate the analyte from alternatives. Q2(R2) describes reference comparisons, positive analyte-containing samples, negative samples and examination of structurally related materials. Retention-time matching can contribute but does not automatically demonstrate discrimination of related substances.

For chromatography, critical separation evidence can include resolution of closest-eluting components. The guideline discusses stressed or spiked material as validation approaches; these are not improvised testing instructions for an unknown research sample. A chromatogram alone may not explain assignments, overlap or integration. Record unavailable supporting information rather than inventing a validation status. ICH Q2(R2), §§3.1.1–3.1.2

An additional well-characterized method, ideally with a different measurement principle, can address inadequate discrimination. This is not a rule prescribing one universal instrument pair for every peptide. Combined evidence must address relevant alternatives and interferences.

Chromatographic area percentage and quantitative content have different purposes and calculation bases. Do not convert area percentage into container mass without a procedure and calculation that justify it. Read the applicable criterion and numerical result together. ICH Q7, §11.43

The bounded conclusion is that a sample met or did not meet an analytical criterion under a defined procedure—not an unmeasured claim about stability, microbial properties or biological activity.